David Foehr, the Senior VP of $CBLL, sold 1,157 shares of the company on 03-03-2026 for an estimated $20,594. We received data on the trade from a recent SEC filing. This was a sale of approximately 6.2% of their shares of this class of stock. Following this trade, they now own 17,550 shares of this class of $CBLL stock.
$CBLL Insider Trading Activity
$CBLL insiders have traded $CBLL stock on the open market 55 times in the past 6 months. Of those trades, 0 have been purchases and 55 have been sales.
Here’s a breakdown of recent trading of $CBLL stock by insiders over the last 6 months:
- XINGJUAN CHAO (President and CEO) has made 0 purchases and 13 sales selling 259,084 shares for an estimated $4,829,844.
- JOSEF PARVIZI has made 0 purchases and 6 sales selling 100,000 shares for an estimated $2,121,762.
- RAYMOND WOO (Chief Technology Officer) has made 0 purchases and 14 sales selling 78,489 shares for an estimated $1,227,369.
- SCOTT BLUMBERG (Chief Financial Officer) has made 0 purchases and 4 sales selling 36,808 shares for an estimated $771,990.
- WILLIAM W BURKE has made 0 purchases and 2 sales selling 32,728 shares for an estimated $720,670.
- DAVID FOEHR (Senior VP, Finance and PAO) has made 0 purchases and 11 sales selling 22,287 shares for an estimated $433,328.
- REBECCA B ROBERTSON has made 0 purchases and 4 sales selling 9,154 shares for an estimated $183,231.
- JOSEPH S. MANNI (Chief Revenue Officer) sold 768 shares for an estimated $15,198
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CBLL Hedge Fund Activity
We have seen 74 institutional investors add shares of $CBLL stock to their portfolio, and 55 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BANK OF NEW YORK MELLON CORP added 1,162,200 shares (+1945.9%) to their portfolio in Q4 2025, for an estimated $25,487,046
- NOVO HOLDINGS A/S removed 900,000 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $10,341,000
- YU FAN removed 803,718 shares (-59.4%) from their portfolio in Q4 2025, for an estimated $17,625,535
- ABG-WTT GLOBAL LIFE SCIENCE CAPITAL PARTNERS GP LTD removed 646,281 shares (-59.4%) from their portfolio in Q4 2025, for an estimated $14,172,942
- FMR LLC removed 552,873 shares (-12.3%) from their portfolio in Q4 2025, for an estimated $12,124,504
- ROYCE & ASSOCIATES LP added 533,300 shares (+inf%) to their portfolio in Q4 2025, for an estimated $11,695,269
- CENTERBOOK PARTNERS LP removed 476,554 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $10,450,829
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CBLL Analyst Ratings
Wall Street analysts have issued reports on $CBLL in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 01/28/2026
- JP Morgan issued a "Overweight" rating on 11/05/2025
- TD Cowen issued a "Buy" rating on 11/05/2025
- Raymond James issued a "Strong Buy" rating on 10/21/2025
To track analyst ratings and price targets for $CBLL, check out Quiver Quantitative's $CBLL forecast page.
$CBLL Price Targets
Multiple analysts have issued price targets for $CBLL recently. We have seen 5 analysts offer price targets for $CBLL in the last 6 months, with a median target of $20.0.
Here are some recent targets:
- Marie Thibault from BTIG set a target price of $30.0 on 01/28/2026
- William Plovanic from Canaccord Genuity set a target price of $30.0 on 12/17/2025
- Joshua Jennings from TD Cowen set a target price of $20.0 on 11/05/2025
- Robbie Marcus from JP Morgan set a target price of $17.0 on 11/05/2025
- Jayson Bedford from Raymond James set a target price of $19.0 on 10/21/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
